Anavex Life Sciences Corp (AVXL)
Operating Income Growth
44.19%
TTM · Period ending:
AVXL Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported44.19%period ending
Latest reported44.19%period ending
AVXL TTM Operating Income YoY % (81.35% → 44.19%)
Year-over-year change
High-resolution chart · PNG
AVXL operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 44.1913% | |
| 29.9306% | |
| 19.1406% | |
| 2.8957% | |
| -7.1069% | |
| -9.6818% | |
| -6.5773% | |
| 5.0082% | |
| 12.1766% | |
| 12.4041% | |
| 5.2548% | |
| -9.3092% | |
| -21.7092% | |
| -22.2867% | |
| -23.3705% | |
| -21.5479% | |
| -28.8966% | |
| -37.9805% | |
| -35.3592% | |
| -35.5828% | |
| -25.2558% | |
| -18.4417% | |
| -12.6537% | |
| -7.395% | |
| -4.7637% | |
| -11.0178% | |
| -29.0927% | |
| -50.1626% | |
| -52.8557% | |
| -46.3828% | |
| -36.3269% | |
| -23.4572% | |
| -9.6387% | |
| -13.6121% | |
| -17.109% | |
| -4.4544% | |
| -37.6693% | |
| -34.3701% | |
| -37.3042% | |
| -109.2749% | |
| -224.9694% | |
| -253.6732% | |
| -199.1308% | |
| -139.4333% | |
| 0.3737% | |
| -11.7886% | |
| -69.0828% | |
| -39.1019% | |
| -188.4542% | |
| -54.9522% | |
| 20.5624% | |
| 50.6724% | |
| 73.1805% | |
| 67.726% | |
| 63.4951% | |
| 29.9402% | |
| 29.0349% | |
| 11.2082% | |
| -13.6838% | |
| -9.034% | |
| -25.6655% | |
| -20.6325% | |
| -30.6588% | |
| -19.5937% | |
| -4.2212% | |
| -1.8213% | |
| 10.4538% | |
| 11.333% | |
| -27.5357% | |
| -75.285% | |
| -105.9174% | |
| -238.6283% | |
| -835.2929% | |
| -1,486.8905% | |
| -8,854.3858% | |
| -6,063.895% | |
| -619.6643% | |
| -89.7813% | |
| 79.9899% | |
| 81.3522% |